Balanced Pharma
Cornelius, US · Founded 2020 · Delaware corporation
Balanced Pharma develops pharmaceutical and medical device products for dental and dermatological applications. The company is led by experienced executives and clinicians with backgrounds in pharmaceutical manufacturing, dentistry, and medical device innovation.
Founders & leadership
Balanced Pharma was founded in 2020 by Scott Keadle.
SK
Scott KeadleinFounder & CEO
JS
John Scott KeadleExecutive
Board
MS
MARK SEBREEBoard director
JS
John SeligBoard director
AZ
ATIF ZIABoard director
Reported raises · per SEC filings
Form D private placements$5.9M disclosed across 4 rounds · 2020–2024
▶$3.2MraisedSep 2025 · 1 investors · PharmaceuticalsRule 506(b)
▶$3.2MraisedSep 2025 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- MARK SEBREEDirector
- JOHN SCOTT KEADLEExecutive Officer, Director
- JOHN SELIGDirector
- ATIF ZIADirector
- RICHARD NONELLEDirector
- Offering amount
- $3.2M
- Amount sold
- $3.2M
- First sale
- Nov 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$175KraisedJan 2025 · 2 investors · PharmaceuticalsRule 506(b)
▶$175KraisedJan 2025 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- JOHN SCOTT KEADLEExecutive Officer, Director
- ATIF ZIADirector
- MARK SEBREEDirector
- JOHN SELIGDirector
- Offering amount
- $2M
- Amount sold
- $175K
- First sale
- Dec 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$498KraisedDec 2024 · 19 investors · PharmaceuticalsRule 506(b)
▶$498KraisedDec 2024 · 19 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- MARK SEBREEDirector
- JOHN SELIGDirector
- JOHN SCOTT KEADLEExecutive Officer, Director
- ATIF ZIADirector
- Offering amount
- $498K
- Amount sold
- $498K
- First sale
- Dec 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$2MraisedFeb 2022 · 44 investors · PharmaceuticalsRule 506(b)
▶$2MraisedFeb 2022 · 44 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- John Scott KeadleExecutive Officer, Director
- John SeligDirector
- Offering amount
- $2M
- Amount sold
- $2M
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
Radiuspharm5 shared keywordsRadius is a biopharmaceutical company focused on bone health and related therapeutic areas for underserved patient populations. It markets commercial products in the U.S., including TYMLOS (abaloparatide) injection and BINOSTO (alendronate sodium).
Bionpharma5 shared keywords
Companies competing with Balanced Pharma for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Balanced Pharma do?
- Balanced Pharma develops pharmaceutical and medical device products for dental and dermatological applications. The company is led by experienced executives and clinicians with backgrounds in pharmaceutical manufacturing, dentistry, and medical device innovation.
- Who founded Balanced Pharma?
- Balanced Pharma was founded by Scott Keadle in 2020.
- How much funding has Balanced Pharma raised?
- Balanced Pharma has disclosed $5.9M raised across 4 rounds.
- Where is Balanced Pharma headquartered?
- Balanced Pharma is headquartered in Cornelius, US.